Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease
Chao Zhang(Yale University), Stefan Somlo(Yale University)
Cited by 22
Related Papers
Mutations in SEC63 cause autosomal dominant polycystic liver disease
|Nature Genetics|2004|282